West African Ebola epidemic after one year--slowing but not yet under control.

PubWeight™: 2.96‹?› | Rank: Top 1%

🔗 View Article (PMC 4368109)

Published in N Engl J Med on December 24, 2014

Authors

WHO Ebola Response Team, Junerlyn Agua-Agum, Archchun Ariyarajah, Bruce Aylward, Isobel M Blake, Richard Brennan, Anne Cori, Christl A Donnelly, Ilaria Dorigatti, Christopher Dye, Tim Eckmanns, Neil M Ferguson, Pierre Formenty, Christophe Fraser, Erika Garcia, Tini Garske, Wes Hinsley, David Holmes, Stéphane Hugonnet, Swathi Iyengar, Thibaut Jombart, Ravi Krishnan, Sascha Meijers, Harriet L Mills, Yasmine Mohamed, Gemma Nedjati-Gilani, Emily Newton, Pierre Nouvellet, Louise Pelletier, Devin Perkins, Steven Riley, Maria Sagrado, Johannes Schnitzler, Dirk Schumacher, Anita Shah, Maria D Van Kerkhove, Olivia Varsaneux, Niluka Wijekoon Kannangarage

Articles citing this

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 3.31

Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet (2016) 2.42

Ebola virus disease among children in West Africa. N Engl J Med (2015) 2.17

Characteristics and Clinical Management of a Cluster of 3 Patients With Ebola Virus Disease, Including the First Domestically Acquired Cases in the United States. Ann Intern Med (2015) 1.47

Temporal Changes in Ebola Transmission in Sierra Leone and Implications for Control Requirements: a Real-time Modelling Study. PLoS Curr (2015) 1.45

Use of Viremia to Evaluate the Baseline Case Fatality Ratio of Ebola Virus Disease and Inform Treatment Studies: A Retrospective Cohort Study. PLoS Med (2015) 1.32

A review of epidemiological parameters from Ebola outbreaks to inform early public health decision-making. Sci Data (2015) 1.20

The role of rapid diagnostics in managing Ebola epidemics. Nature (2015) 1.11

Ebola Virus Disease among Male and Female Persons in West Africa. N Engl J Med (2016) 1.08

Mathematical modeling of the West Africa Ebola epidemic. Elife (2015) 1.07

Transmission dynamics of Ebola virus disease and intervention effectiveness in Sierra Leone. Proc Natl Acad Sci U S A (2016) 1.02

Modeling household and community transmission of Ebola virus disease: Epidemic growth, spatial dynamics and insights for epidemic control. Virulence (2015) 1.01

Assembly of the Ebola Virus Nucleoprotein from a Chaperoned VP35 Complex. Cell Rep (2015) 0.99

The 2014 Ebola virus disease outbreak in Pujehun, Sierra Leone: epidemiology and impact of interventions. BMC Med (2015) 0.99

Ebola virus disease in the Democratic Republic of the Congo, 1976-2014. Elife (2015) 0.99

Antiviral therapies against Ebola and other emerging viral diseases using existing medicines that block virus entry. F1000Res (2015) 0.92

Exposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational Study. PLoS Med (2016) 0.91

Transmission network of the 2014-2015 Ebola epidemic in Sierra Leone. J R Soc Interface (2015) 0.91

Exposure-Specific and Age-Specific Attack Rates for Ebola Virus Disease in Ebola-Affected Households, Sierra Leone. Emerg Infect Dis (2016) 0.90

Clinical Features of and Risk Factors for Fatal Ebola Virus Disease, Moyamba District, Sierra Leone, December 2014-February 2015. Emerg Infect Dis (2016) 0.86

Interferon-Induced Transmembrane Protein-Mediated Inhibition of Host Cell Entry of Ebolaviruses. J Infect Dis (2015) 0.86

Characterizing Ebola Transmission Patterns Based on Internet News Reports. Clin Infect Dis (2015) 0.83

Retrospective Analysis of the 2014-2015 Ebola Epidemic in Liberia. Am J Trop Med Hyg (2016) 0.82

Ebola Virus Disease in Children, Sierra Leone, 2014-2015. Emerg Infect Dis (2016) 0.81

High-Throughput Minigenome System for Identifying Small-Molecule Inhibitors of Ebola Virus Replication. ACS Infect Dis (2015) 0.79

Development of Prototype Filovirus Recombinant Antigen Immunoassays. J Infect Dis (2015) 0.79

Key data for outbreak evaluation: building on the Ebola experience. Philos Trans R Soc Lond B Biol Sci (2017) 0.79

Assessing the direct effects of the ebola outbreak on life expectancy in liberia, sierra leone and Guinea. PLoS Curr (2015) 0.79

Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis. BMC Med (2016) 0.79

Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016. Philos Trans R Soc Lond B Biol Sci (2017) 0.79

The potential for sexual transmission to compromise control of Ebola virus outbreaks. Biol Lett (2016) 0.79

Estimating the probability of demonstrating vaccine efficacy in the declining Ebola epidemic: a Bayesian modelling approach. BMJ Open (2015) 0.79

Strengthening Health Systems While Responding to a Health Crisis: Lessons Learned by a Nongovernmental Organization During the Ebola Virus Disease Epidemic in Sierra Leone. J Infect Dis (2016) 0.79

Novel Chemical Ligands to Ebola Virus and Marburg Virus Nucleoproteins Identified by Combining Affinity Mass Spectrometry and Metabolomics Approaches. Sci Rep (2016) 0.78

Ebola response in Sierra Leone: The impact on children. J Infect (2016) 0.78

RNA Binding of Ebola Virus VP30 Is Essential for Activating Viral Transcription. J Virol (2016) 0.78

Addressing the Complications of Ebola and Other Viral Hemorrhagic Fever Infections: Using Insights from Bacterial and Fungal Sepsis. PLoS Pathog (2015) 0.76

Functional characterization of adaptive mutations during the West African Ebola virus outbreak. J Virol (2016) 0.76

Spatial and temporal dynamics of superspreading events in the 2014-2015 West Africa Ebola epidemic. Proc Natl Acad Sci U S A (2017) 0.75

13th ERS Lung Science Conference. The most important take home messages: News from the Underground. Breathe (Sheff) (2015) 0.75

Predicting and Evaluating the Epidemic Trend of Ebola Virus Disease in the 2014-2015 Outbreak and the Effects of Intervention Measures. PLoS One (2016) 0.75

Modernising epidemic science: enabling patient-centred research during epidemics. BMC Med (2016) 0.75

Spatiotemporal Analysis of the 2014 Ebola Epidemic in West Africa. PLoS Comput Biol (2016) 0.75

Reduced Risk of Importing Ebola Virus Disease because of Travel Restrictions in 2014: A Retrospective Epidemiological Modeling Study. PLoS One (2016) 0.75

The Effect of Community-Based Prevention and Care on Ebola Transmission in Sierra Leone. Am J Public Health (2016) 0.75

Ebola virus disease in children during the 2014-2015 epidemic in Guinea: a nationwide cohort study. Eur J Pediatr (2017) 0.75

Improving Ebola infection prevention and control in primary healthcare facilities in Sierra Leone: a single-group pretest post-test, mixed-methods study. BMJ Glob Health (2016) 0.75

Articles by these authors

Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01

Strategies for containing an emerging influenza pandemic in Southeast Asia. Nature (2005) 30.92

Ebola virus disease in West Africa--the first 9 months of the epidemic and forward projections. N Engl J Med (2014) 28.65

Pandemic potential of a strain of influenza A (H1N1): early findings. Science (2009) 26.24

Strategies for mitigating an influenza pandemic. Nature (2006) 25.20

The growing burden of tuberculosis: global trends and interactions with the HIV epidemic. Arch Intern Med (2003) 24.99

Emergence of Zaire Ebola virus disease in Guinea. N Engl J Med (2014) 16.45

Transmission dynamics of the etiological agent of SARS in Hong Kong: impact of public health interventions. Science (2003) 12.26

Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet (2003) 10.74

Time lines of infection and disease in human influenza: a review of volunteer challenge studies. Am J Epidemiol (2008) 10.02

Rapid pneumococcal evolution in response to clinical interventions. Science (2011) 9.09

Factors that make an infectious disease outbreak controllable. Proc Natl Acad Sci U S A (2004) 8.38

Modeling targeted layered containment of an influenza pandemic in the United States. Proc Natl Acad Sci U S A (2008) 8.27

Estimating the impact of school closure on influenza transmission from Sentinel data. Nature (2008) 7.98

Estimates of world-wide distribution of child deaths from acute respiratory infections. Lancet Infect Dis (2002) 6.73

Closure of schools during an influenza pandemic. Lancet Infect Dis (2009) 6.68

Assessing the severity of the novel influenza A/H1N1 pandemic. BMJ (2009) 6.66

Household transmission of 2009 pandemic influenza A (H1N1) virus in the United States. N Engl J Med (2009) 6.65

HIV-1 transmission, by stage of infection. J Infect Dis (2008) 6.57

The potential impact of male circumcision on HIV in Sub-Saharan Africa. PLoS Med (2006) 6.53

Tuberculosis. Lancet (2003) 6.39

The TetR family of transcriptional repressors. Microbiol Mol Biol Rev (2005) 6.02

Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med (2009) 5.93

The severity of pandemic H1N1 influenza in the United States, from April to July 2009: a Bayesian analysis. PLoS Med (2009) 5.86

The effect of public health measures on the 1918 influenza pandemic in U.S. cities. Proc Natl Acad Sci U S A (2007) 5.73

Sinus of Valsalva aneurysms--47 years of a single center experience and systematic overview of published reports. Am J Cardiol (2007) 5.71

Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med (2010) 5.71

Multiple Ebola virus transmission events and rapid decline of central African wildlife. Science (2004) 5.49

Global incidence of multidrug-resistant tuberculosis. J Infect Dis (2006) 5.42

The international Ebola emergency. N Engl J Med (2014) 5.35

An Aboriginal Australian genome reveals separate human dispersals into Asia. Science (2011) 4.84

Hand hygiene among physicians: performance, beliefs, and perceptions. Ann Intern Med (2004) 4.63

Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nat Genet (2010) 4.35

Monitoring mosquito net coverage for malaria control in Africa: possession vs. use by children under 5 years. Trop Med Int Health (2003) 4.29

Human Ebola outbreak resulting from direct exposure to fruit bats in Luebo, Democratic Republic of Congo, 2007. Vector Borne Zoonotic Dis (2009) 4.24

Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. Lancet Infect Dis (2003) 4.10

HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08

Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med (2011) 4.02

Estimation of the reproductive number and the serial interval in early phase of the 2009 influenza A/H1N1 pandemic in the USA. Influenza Other Respir Viruses (2009) 4.02

Will travel restrictions control the international spread of pandemic influenza? Nat Med (2006) 3.89

Reducing the impact of the next influenza pandemic using household-based public health interventions. PLoS Med (2006) 3.86

Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature (2006) 3.72

Public health. Public health risk from the avian H5N1 influenza epidemic. Science (2004) 3.71

Feasibility and cost-effectiveness of standardised second-line drug treatment for chronic tuberculosis patients: a national cohort study in Peru. Lancet (2002) 3.67

Late-acting dominant lethal genetic systems and mosquito control. BMC Biol (2007) 3.54

Panmicrobial oligonucleotide array for diagnosis of infectious diseases. Emerg Infect Dis (2007) 3.51

The infection attack rate and severity of 2009 pandemic H1N1 influenza in Hong Kong. Clin Infect Dis (2010) 3.51

Fuzzy species among recombinogenic bacteria. BMC Biol (2005) 3.47

Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned. BMC Infect Dis (2011) 3.45

Antiretroviral therapy for prevention of tuberculosis in adults with HIV: a systematic review and meta-analysis. PLoS Med (2012) 3.44

School closure and mitigation of pandemic (H1N1) 2009, Hong Kong. Emerg Infect Dis (2010) 3.42

Marburg hemorrhagic fever associated with multiple genetic lineages of virus. N Engl J Med (2006) 3.38

Studies of reservoir hosts for Marburg virus. Emerg Infect Dis (2007) 3.35

Host immunity and synchronized epidemics of syphilis across the United States. Nature (2005) 3.34

The conduct of in vitro and in vivo drug-drug interaction studies: a Pharmaceutical Research and Manufacturers of America (PhRMA) perspective. Drug Metab Dispos (2003) 3.33

Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med (2002) 3.33

Alcohol use as a risk factor for tuberculosis - a systematic review. BMC Public Health (2008) 3.32

Diabetes and the risk of tuberculosis: a neglected threat to public health? Chronic Illn (2007) 3.31

Managing and reducing uncertainty in an emerging influenza pandemic. N Engl J Med (2009) 3.31

New strategies for the elimination of polio from India. Science (2006) 3.27

Human immunodeficiency virus and the prevalence of undiagnosed tuberculosis in African gold miners. Am J Respir Crit Care Med (2004) 3.26

Field performance of engineered male mosquitoes. Nat Biotechnol (2011) 3.25

CD4 cell counts of 800 cells/mm3 or greater after 7 years of highly active antiretroviral therapy are feasible in most patients starting with 350 cells/mm3 or greater. J Acquir Immune Defic Syndr (2007) 3.18

Risk factors associated with subclinical human infection with avian influenza A (H5N1) virus--Cambodia, 2006. J Infect Dis (2009) 3.05

Implications of a circulating vaccine-derived poliovirus in Nigeria. N Engl J Med (2010) 3.00

Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA (2007) 2.99